SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
scaram(o)uche
To: jesspro who wrote (4436)12/8/2016 8:51:17 PM
From: jaybe1 Recommendation  Read Replies (1) of 4474
 
No chance, '788 is progressing through dose escalation. I've heard early doses were safe and they are likely reaching efficacious doses around now. We will not hear first data until ESMO (Sept 8-12) or WCLC (Oct 15-18). Its possible that more pre-clinical data on other mutations or indications could be presented at AACR (Apr 1-5).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News